
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.
Some "herbal" products marketed as having efficacy similarto PDE-5 inhibitors without the side effects and the need for medical monitoringactually contain pharmacologic concentrations of PDE-5 inhibitors, accordingto the results of a Canadian study presented here. Separately, Britishresearchers confirmed what many urologists already know-that informationabout herbal ED therapies sold on the Internet is unreliable and misleading.





